Dr. Prasad Departs FDA, Leaving Biotech Reviews Uncertain
US News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Vinay Prasad, the director of the FDAs Center for Biologics Evaluation and Research, is stepping down after a year-long tenure overseeing vaccine and biotech product approvals. Despite praise for his work, his time at the FDA was marked by debates over high-profile regulatory calls, such as those with Sarepta Therapeutics and UniQure. As he leaves, questions remain about the impact of his policies on future approvals.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/3dc790ef22e5f6f4